Skip to main content
. 2020 Aug 5;10:270. doi: 10.1038/s41398-020-00938-8

Table 1.

Participant characteristics for PTSD (treatment responders and nonresponders) and healthy controls.

PTSD (n = 36) Controls (n = 36) Treatment responders (n = 25) Treatment nonresponders (n = 11)
Age, mean (SD) 39.7 ± 11.3 38.3 ± 12.9 40.2 ± 12.4 38.6 ± 8.6
Male, n (%) 53% 50% 48% 63.6%
Time since trauma, months mean (SD) 17.5 ± 14.0 18.6 ± 15.3 14.9 ± 10.6
Type of trauma, n (%)
 Childhood abuse 3 (8.3) 3 (12) 0 (0)
 Motor vehicle accident 5 (13.9) 2 (8) 3 (27.3)
 Police-related trauma 10 (27.8) 8 (32) 3 (27.3)
 Assault 14 (38.9) 9 (36) 5 (36.4)
 Witness 3 (8.3) 3 (12) 0 (0)
Prescribed SSRI, n (%) 10 (27.8) 8 (32) 2 (18.2)
Major depressive disorder, n (%) 19 (52.8) 12 (48) 7 (63.6)
Social phobia, n (%) 15 (41.7) 8 (32) 7 (63.6)
Panic disorder, n (%) 5 (13.9) 4 (16) 1 (9.1)
Agoraphobia, n (%) 23 (63.9) 17 (68) 6 (54.6)
Obsessive compulsive disorder, n (%) 4 (11.1) 2 (8) 2 (18.2)
Generalized anxiety disorder, n (%) 12 (33.3) 8 (32) 4 (36.4)
DASS depression, mean (SD) 10.9 ± 5.5 10.5 ± 5.8 11.8 ± 3.9
DASS anxiety, mean (SD) 8.1 ± 4.4 7.2 ± 4.8 10.1 ± 2.3
DASS stress, mean (SD) 12.0 ± 4.4 11.4 ± 4.6 13.5 ± 3.5
Baseline CAPS severity, mean (SD) 72.2 ± 14.0 71.9 ± 20.1 72.7 ± 11.1
Post-treatment CAPS severity, mean (SD) 27.5 ± 19.6 17.2 ± 12.1* 51.0 ± 10.8*

PTSD post-traumatic stress disorder, CAPS clinician-administered PTSD scale, DASS21 depression anxiety stress scale—21 items.

* indicates a significant difference at P < 0.05 between treatment responders and nonresponders.